Literature DB >> 8863152

German family study on hereditary breast-ovarian cancer.

U Hamann1, H Becher, T Zimmermann, K Pella, G Bastert, J Chang-Claude.   

Abstract

An estimated 5% to 10% of all breast and ovarian cancers are attributed to dominant susceptibility genes. Two such genes, BRCA1 and BRCA2, were recently identified. The involvement of these genes was studied in 43 German breast only and breast-ovarian cancer families. All families contained three or more cases of breast or ovarian cancer, with at least two diagnosed under the age of 60 years. Multipoint linkage analysis gave a maximum lod score of 2.13 at the BRCA1 locus under the assumption of genetic heterogeneity, with an estimated 50% of families being linked. Among the 33 breast only cancer and 10 breast-ovarian cancer families, the estimated proportions of linked families were 35% and 75%, respectively. Sixteen families with at least four cases of female breast cancer diagnosed under the age of 60 years, or male breast cancer diagnosed at any age, were analysed for linkage to BRCA2. Positive lod scores at BRCA2 were obtained in six families.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8863152      PMCID: PMC1050694          DOI: 10.1136/jmg.33.8.633

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  21 in total

1.  The 1993-94 Généthon human genetic linkage map.

Authors:  G Gyapay; J Morissette; A Vignal; C Dib; C Fizames; P Millasseau; S Marc; G Bernardi; M Lathrop; J Weissenbach
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

2.  Identification of the breast cancer susceptibility gene BRCA2.

Authors:  R Wooster; G Bignell; J Lancaster; S Swift; S Seal; J Mangion; N Collins; S Gregory; C Gumbs; G Micklem
Journal:  Nature       Date:  1995 Dec 21-28       Impact factor: 49.962

3.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

4.  Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families.

Authors:  L S Friedman; E A Ostermeyer; C I Szabo; P Dowd; E D Lynch; S E Rowell; M C King
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

5.  Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer.

Authors:  L H Castilla; F J Couch; M R Erdos; K F Hoskins; K Calzone; J E Garber; J Boyd; M B Lubin; M L Deshano; L C Brody
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

6.  Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families.

Authors:  J Simard; P Tonin; F Durocher; K Morgan; J Rommens; S Gingras; C Samson; J F Leblanc; C Bélanger; F Dion
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

7.  Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Authors:  D F Easton; D Ford; D T Bishop
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

8.  A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening.

Authors:  D Shattuck-Eidens; M McClure; J Simard; F Labrie; S Narod; F Couch; K Hoskins; B Weber; L Castilla; M Erdos
Journal:  JAMA       Date:  1995-02-15       Impact factor: 56.272

9.  Rapid detection of BRCA1 mutations by the protein truncation test.

Authors:  F B Hogervorst; R S Cornelis; M Bout; M van Vliet; J C Oosterwijk; R Olmer; B Bakker; J G Klijn; H F Vasen; H Meijers-Heijboer
Journal:  Nat Genet       Date:  1995-06       Impact factor: 38.330

10.  Linkage analysis of BRCA1 in Japanese breast cancer families.

Authors:  R Inoue; T Fukutomi; T Ushijima; Y Matsumoto; T Sugimura; M Nagao
Journal:  Jpn J Cancer Res       Date:  1994-12
View more
  4 in total

1.  Modifying effect of reproductive risk factors on the age at onset of breast cancer for German BRCA1 mutation carriers.

Authors:  J Chang-Claude; H Becher; N Eby; G Bastert; J Wahrendorf; U Hamann
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

2.  Using gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genes.

Authors:  J Chang-Claude; J Dong; S Schmidt; M Shayeghi; D Komitowski; H Becher; M R Stratton; B Royer-Pokora
Journal:  J Med Genet       Date:  1998-02       Impact factor: 6.318

3.  Low frequency of BRCA1 germline mutations in 45 German breast/ovarian cancer families.

Authors:  U Hamann; M Häner; U Stosiek; G Bastert; R J Scott
Journal:  J Med Genet       Date:  1997-11       Impact factor: 6.318

4.  Intronic TP53 Germline Sequence Variants Modify the Risk in German Breast/Ovarian Cancer Families.

Authors:  Xuan Liu; Hans-Peter Sinn; Hans Ulrich Ulmer; Rodney J Scott; Ute Hamann
Journal:  Hered Cancer Clin Pract       Date:  2004-07-15       Impact factor: 2.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.